Back to top

MIWG was formed in 2006 to seek clarity in the FDA regulatory scheme regarding the dissemination of truthful non-misleading information about prescription drugs, biological products and medical devices, and to improve the federal regulatory framework and enforcement climate affecting manufacturer dissemination of information regarding those products (including products in development and new uses of marketed products).


FDA Submissions and Amicus Briefs Filed on Behalf of MIWG Members.